Financial Metrics Exploration: Understanding Regulus Therapeutics Inc (RGLS) Through Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

The closing price of Regulus Therapeutics Inc (NASDAQ: RGLS) was $7.83 for the day, down -0.25% from the previous closing price of $7.85. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 0.94 million shares were traded.

Ratios:

Our analysis of RGLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.52 and its Current Ratio is at 10.52. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 27, 2025, Upgraded its rating to Overweight and sets its target price to $6 from $3 previously.

On August 02, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $7.

On March 18, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $6.Leerink Partners initiated its Outperform rating on March 18, 2024, with a $6 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 30 ’25 when Hagan Joseph P bought 50,000 shares for $1.09 per share. The transaction valued at 54,260 led to the insider holds 260,808 shares of the business.

BALTIMORE DAVID bought 19,610 shares of RGLS for $20,787 on Jan 30 ’25. The Director now owns 22,169 shares after completing the transaction at $1.06 per share. On Jan 13 ’25, another insider, Aker Christopher Ray, who serves as the Sr. VP & General Counsel of the company, sold 38,547 shares for $1.26 each. As a result, the insider received 48,693 and left with 54,634 shares of the company.

Stock Price History:

Over the past 52 weeks, RGLS has reached a high of $8.20, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is 234.92%, while the 200-Day Moving Average is calculated to be 356.87%.

Shares Statistics:

A total of 65.50M shares are outstanding, with a floating share count of 52.53M. Insiders hold about 20.70% of the company’s shares, while institutions hold 67.85% stake in the company.

Most Popular